Company Filing History:
1 out of 289 
1 out of 3,539 
Years Active: 2009-2013
Title: Paul L Boyer: Innovator in HIV Treatment and Reverse Transcriptase Research
Introduction
Paul L Boyer is a notable inventor based in Greencastle, PA (US). He has made significant contributions to the field of biomedical research, particularly in the development of compounds for treating HIV and advancements in reverse transcriptase technology. With a total of 2 patents, his work has the potential to impact the treatment of viral infections.
Latest Patents
Boyer's latest patents include innovative approaches to HIV treatment. One of his inventions, titled "C4'-substituted-2-deoxyadenosine analogs and methods of treating HIV," provides novel 2-Deoxyadenosine compounds that can treat HIV infection with low cytotoxicity values. The substitution at the 4'-position has resulted in compounds that demonstrate low cytotoxicity in ATP-based cytotoxicity assays. Another significant patent is for a "Foamy virus mutant reverse transcriptase," which relates to a highly processive reverse transcriptase exhibiting DNA polymerase activity and substantially reduced protease activity. This invention includes an isolated reverse transcriptase from foamy virus and methods for producing cDNA from polynucleotides using this highly processive reverse transcriptase.
Career Highlights
Throughout his career, Boyer has worked with prestigious organizations such as the Fred Hutchinson Cancer Center and the United States Department of Health and Human Services. His research has focused on developing effective treatments for viral infections, showcasing his commitment to advancing medical science.
Collaborations
Boyer has collaborated with esteemed colleagues in his field, including Stephen H Hughes and Maxine Linial. These partnerships have contributed to the success and impact of his research endeavors.
Conclusion
Paul L Boyer is a distinguished inventor whose work in HIV treatment and reverse transcriptase research has the potential to make a significant difference in the medical field. His innovative patents and collaborations highlight his dedication to advancing healthcare solutions.